Comparison of PHVP of Different VTH Methods
NCT03858673
Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms
View Trial DetailsNCT Number: NCT03832543
Introduction : The extraperitoneal uterosacral ligament suspension (ULS) can be performed during the removal of the uterus in vaginal hysterectomy to prevent cuff prolapse. In this study, the modified extraperitoneal ULS technique was evaluated in terms of preventing cuff prolapse.
Methods / Technique : Forty patients with second and third-stage uterine prolapse who were operated were included in the study. During routine vaginal hysterectomy procedure performed on patients, after sacrouterine ligaments which are the first-bites and uteroovarian and round ligaments which are the last-bites have been sutured and knotted, these ligaments were marked with 4-distinct clemps to make the right and left, upper and lower separation. After vaginal cuff was closed the sutures hanged by the clamps were ligated together, and the cuff tissue was stretched to the apical line.
Looking for future studies?
Notify Me40 year–75 year
Female
Observational
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 2 years
During two years follow up after sugery if there is vaginal cuff prolapse or not. The measurement of the vaginal cuff distance to the hymenal ring with a calculator. The units were centimeter
Kanuni Sultan Suleyman Training and Research Hospital
Other
Modified Extraperitoneal Uterosacral Ligament Suspension in Preventing Cuff Prolapse Risk After Vaginal Hysterectomy; 4 Clamp Method
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03858673
Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms
View Trial DetailsNCT04378400
Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms
Leuven, Belgium
View Trial DetailsNCT06524700
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Cairo, Cairo Governorate, Egypt
View Trial DetailsNCT02890498
Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms
Nîmes, France
View Trial Details